Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (AU1991085466) Imidoester cross-linked hemoglobin compositions

Office : Australia
Application Number: 85466/91 Application Date: 03.10.1991
Publication Number: 1991085466 Publication Date: 16.06.1994
Publication Kind : A
Prior PCT appl.: Application Number:US1991007155 ; Publication Number: Click to see the data
IPC:
C07K 14/00
A61K 38/00
C07K 1/107
C07K 1/14
C07K 14/805
A61K 38/16
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
1
General processes for the preparation of peptides
107
by chemical modification of precursor peptides
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
1
General processes for the preparation of peptides
14
Extraction; Separation; Purification
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
795
Porphyrin- or corrin-ring-containing peptides
805
Haemoglobins; Myoglobins
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
CPC:
C07K 14/805
A61K 38/00
Applicants: Upjohn Company, The
Inventors:
Agents: Phillips Ormonde Fitzpatrick
Priority Data: 619840 29.11.1990 US
Title: (EN) Imidoester cross-linked hemoglobin compositions
Abstract:
(EN) An imidoester, cross-linked hemoglobin composition useful in the transport of oxygen to living cells and being essentially free of any impurities, a P50 of at least 13 mM Hg and predominantly in tetramer form. Preferably, the cross-linked hemoglobin composition has a predominant molecular weight of at least 64,000. The purified and cross-linked hemoglobin has improved cross-link stability to autoxidation and can be used as a blood substitute for mammals or as an oxygen transport fluid.
Also published as:
CZPV1993-854FI932461NO19931956SK54993IL99785EP0559655
US5362855JPH06502848CA2093650WO/1992/009630